Form 8-K - Current report:
SEC Accession No. 0001193125-23-030281
Filing Date
2023-02-09
Accepted
2023-02-09 17:01:07
Documents
14
Period of Report
2023-02-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d457771d8k.htm   iXBRL 8-K 38579
2 EX-4.1 d457771dex41.htm EX-4.1 90655
3 EX-10.1 d457771dex101.htm EX-10.1 368731
  Complete submission text file 0001193125-23-030281.txt   745773

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20230203.xsd EX-101.SCH 2871
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20230203_lab.xml EX-101.LAB 18757
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20230203_pre.xml EX-101.PRE 11724
8 EXTRACTED XBRL INSTANCE DOCUMENT d457771d8k_htm.xml XML 3503
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 23607150
SIC: 2834 Pharmaceutical Preparations